Search Results - González-Sales, Mario

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    Wide size dispersion and use of body composition and maturation improves the reliability of allometric exponent estimates

    Wide size dispersion and use of body composition and maturation improves the reliability of allometric exponent estimates by González-Sales, Mario, Holford, Nick, Bonnefois, Guillaume, Desrochers, Julie

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Imetelstat, a novel, first‐in‐class telomerase inhibitor: Mechanism of action, clinical, and translational science

    Imetelstat, a novel, first‐in‐class telomerase inhibitor: Mechanism of action, clinical, and translational science by Lennox, Ashley L., Huang, Fei, Behrs, Melissa Kelly, González‐Sales, Mario, Bhise, Neha, Wan, Ying, Sun, Libo, Berry, Tymara, Feller, Faye, Morcos, Peter N.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Population pharmacokinetics of imetelstat, a first‐in‐class oligonucleotide telomerase inhibitor

    Population pharmacokinetics of imetelstat, a first‐in‐class oligonucleotide telomerase inhibitor by González‐Sales, Mario, Lennox, Ashley L., Huang, Fei, Pamulapati, Chandra, Wan, Ying, Sun, Libo, Berry, Tymara, Kelly Behrs, Melissa, Feller, Faye, Morcos, Peter N.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Modelling the dose–response relationship: the fair share of pharmacokinetic and pharmacodynamic information

    Modelling the dose–response relationship: the fair share of pharmacokinetic and pharmacodynamic information by González‐Sales, Mario, Nekka, Fahima, Tanguay, Mario, Tremblay, Pierre‐Olivier, Li, Jun

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Model‐Based Assessment Using Conventional Bioequivalence Limits to Ensure Safety and Efficacy of Rivaroxaban in Patients Undergoing Hip or Knee Replacement

    Model‐Based Assessment Using Conventional Bioequivalence Limits to Ensure Safety and Efficacy of Rivaroxaban in Patients Undergoing Hip or Knee Replacement by González‐Sales, Mario, Fang, Lanyan, Kim, Myong‐Jin, Zhao, Liang

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Efficacy and safety exposure–response analyses of entrectinib in patients with advanced or metastatic solid tumors

    Efficacy and safety exposure–response analyses of entrectinib in patients with advanced or metastatic solid tumors by Mercier, Francois, Djebli, Nassim, González-Sales, Mario, Jaminion, Felix, Meneses-Lorente, Georgina

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Population pharmacokinetic analysis of entrectinib in pediatric and adult patients with advanced/metastatic solid tumors: support of new drug application submission

    Population pharmacokinetic analysis of entrectinib in pediatric and adult patients with advanced/metastatic solid tumors: support of new drug application submission by González-Sales, Mario, Djebli, Nassim, Meneses-Lorente, Georgina, Buchheit, Vincent, Bonnefois, Guillaume, Tremblay, Pierre-Olivier, Frey, Nicolas, Mercier, François

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Modeling Testosterone Circadian Rhythm in Hypogonadal Males: Effect of Age and Circannual Variations

    Modeling Testosterone Circadian Rhythm in Hypogonadal Males: Effect of Age and Circannual Variations by González-Sales, Mario, Barrière, Olivier, Tremblay, Pierre-Olivier, Nekka, Fahima, Desrochers, Julie, Tanguay, Mario

    Published in The AAPS journal
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Physiologically Based Pharmacokinetic Modeling to Evaluate Formulation Factors Influencing Bioequivalence of Metoprolol Extended‐Release Products

    Physiologically Based Pharmacokinetic Modeling to Evaluate Formulation Factors Influencing Bioequivalence of Metoprolol Extended‐Release Products by Basu, Sumit, Yang, Haitao, Fang, Lanyan, Gonzalez‐Sales, Mario, Zhao, Liang, Trame, Mirjam N., Lesko, Lawrence, Schmidt, Stephan

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  10. 10
    Population Pharmacokinetic Analysis of Tesamorelin in HIV-Infected Patients and Healthy Subjects

    Population Pharmacokinetic Analysis of Tesamorelin in HIV-Infected Patients and Healthy Subjects by González-Sales, Mario, Barrière, Olivier, Tremblay, Pierre Olivier, Nekka, Fahima, Mamputu, Jean-Claude, Boudreault, Sylvie, Tanguay, Mario

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  11. 11
    Assembling Pharmacometric Datasets in R - The puzzle Package

    Assembling Pharmacometric Datasets in R - The puzzle Package by González-Sales, Mario, Barrière, Olivier, Tremblay, Pierre,Olivier, Bonnefois, Guillaume, Desrochers, Julie, Nekka, Fahima

    Published in The R journal
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Population pharmacokinetic and pharmacodynamic analysis of tesamorelin in HIV-infected patients and healthy subjects

    Population pharmacokinetic and pharmacodynamic analysis of tesamorelin in HIV-infected patients and healthy subjects by González-Sales, Mario, Barrière, Olivier, Tremblay, Pierre Olivier, Nekka, Fahima, Mamputu, Jean-Claude, Boudreault, Sylvie, Tanguay, Mario

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  13. 13
    Population Pharmacokinetic–Pharmacodynamic Analysis of Neutropenia in Cancer Patients Receiving PM00104 (Zalypsis®)

    Population Pharmacokinetic–Pharmacodynamic Analysis of Neutropenia in Cancer Patients Receiving PM00104 (Zalypsis®) by González-Sales, Mario, Valenzuela, Belén, Pérez-Ruixo, Carlos, Fernández Teruel, Carlos, Miguel-Lillo, Bernardo, Soto-Matos, Arturo, Pérez-Ruixo, Juan Jose

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  14. 14
    Population pharmacokinetics of PM00104 (Zalypsis®) in cancer patients

    Population pharmacokinetics of PM00104 (Zalypsis®) in cancer patients by Pérez-Ruixo, Carlos, Valenzuela, Belén, Fernández Teruel, Carlos, González-Sales, Mario, Miguel-Lillo, Bernardo, Soto-Matos, Arturo, Pérez-Ruixo, Juan José

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  15. 15
    Abstract 3373: Clinical trial simulation for the individualization of docetaxel dosing

    Abstract 3373: Clinical trial simulation for the individualization of docetaxel dosing by Perez-Ruixo, Carlos, Valenzuela, Belen, González-Sales, Mario, Calvo, Emiliano

    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Abstract 2213: Influence of genetic polymorphism in UGT1A1, UGT1A7 and UGT1A9 on irinotecan, SN-38 and SN-38G pharmacokinetics

    Abstract 2213: Influence of genetic polymorphism in UGT1A1, UGT1A7 and UGT1A9 on irinotecan, SN-38 and SN-38G pharmacokinetics by Valenzuela, Belen, González-Sales, Mario, Escudero, Vanessa, Navarro, Elena, Perez-Ruixo, Carlos, Rebollo, Joseba, González-Manzano, Ramon, Pérez-Ruixo, Juan José

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: